1. Zhang, T., Li, H., Woodberry, K., Xu, L., Tang, Y., Guo, Q., Wang, J. (2016, May). Two-year follow-up of a Chinese sample at clinical high risk for psychosis: timeline of symptoms, help-seeking and conversion. Epidemiology and Psychiatric Sciences, 1-12. doi:10.1017/S2045796016000184
2. Chen, F., Wang, L., Wang, J., Aubeeluck, A. H., Yuan, J., & Zhao, X. (2016, August). Applicability of the Chinese version of the 16-item Prodromal Questionnaire (CPQ-16) for identifying attenuated psychosis syndrome in a college population. Early Intervention Psychiatry, 10(4), 308-315. doi:10.1111/eip.12173
3. Cannon, T. D., Changhong, Y., Jean, A., Bearden, C. E., Cadenhead, K. S., Cornblatt, B. A., Kattan, M. W. (2016, July 1). An individualized risk calculator for research in prodromal psychosis. The American Journal of Psychiatry, 980-988. doi:https://doi.org/10.1176/appi.ajp.2016.15070890
4. Carrion, R. E., Correll, C. U., Auther, A. M., & Cornblatt, B. A. (2017, January 1). A Severity-Based Clinical Staging Model for the Psychosis Prodrome: Longitudinal Findings From the New York Recognition and Prevention Program. Schizophrenia Bulletin, 64-74. doi:https://doi.org/10.1093/schbul/sbw155
5. Zhang, T. H., Xu, L. H., Tang, Y. Y., Li, H. J., Tang, X. C., Cui, H. R., SHARP Study Group. (2018, September 14). Prediction of psychosis in prodrome:. Psychological Medicine, 1990-1998. doi:https://doi.org/10.1017/S0033291718002738
6. Zhang, T. H., Xu, L. H., Tang, X. C., Wei, Y. Y., Hu, Q., Hu, Y. G., Wang, J. J. (2020, July 1). Real-world effectiveness of antipsychotic treatment in psychosis prevention in a 3-year cohort of 517 individuals at clinical high risk from the SHARP (ShangHai At Risk for Psychosis). Australian & New Zealand Journal of Psychiatry, 54(7), 696-706. doi:https://doi.org/10.1177/0004867420917449
7. Li, H., Zhang, T. H., Xu, L. H., Tang, Y. Y., Cui, H. R., Wei, Y. Y., Wang, J. J. (2018). A comparison of conversion rates, clinical profiles and predictors of outcomes in two independent samples of individuals at clinical high risk for psychosis in China. Schizophrenia Research, 197, 509-515. doi:https://doi.org/10.1016/j.schres.2017.11.029
8. McGorry, P. D., Nelson, B., Markulev, C., Yuen, H. P., Schafer, M. R., Mossaheb, N., Amminger, G. P. (2017, January 1). Effect of ω-3 Polyunsaturated Fatty Acids in Young People at Ultrahigh Risk for Psychotic Disorders: The NEURAPRO Randomized Clinical Trial. JAMA Psychiatry, 74(1), 19-27. doi:10.1001/jamapsychiatry.2016.2902.
9. Lieberman, J. A., Small, S. A., & Girgis, R. R. (2019, October 1). Early Detection and Preventive Intervention in Schizophrenia: From Fantasy to Reality. American Journal of Psychiatry, 176(10), 794-810. doi:10.1176/appi.ajp/2019.19080854
10. Xu, L. H., Zhang, T. H., Zheng, L. N., Li, H. J., Tang, Y. Y., Luo, X. G., Wang, J. J. (2016, February 9). Psychometric Properties of Prodromal Questionnaire-Brief Version among Chinese Help-Seeking Individuals. PLOS ONE, 11(2), 1-14. doi:10.1371/journal.pone.0148935
11. Kaligis, F., Marsubrin, R. I., Wiguna, T., Noorhana, S., & Almasyhur, A. F. (2018, August 23). Translation and validation study of the prodromal questionnaire brief version into Indonesian language. Asian Journal Psychiatry, 96-101. doi:10.1016/j.ajp.2018.08.012
Facebook 
Masuk dengan Email
